| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |